NovaBridge Biosciences (NBP) Treasury Shares (2018 - 2025)

NovaBridge Biosciences (NBP) has reported Treasury Shares for 5 consecutive years, with -$5.0 million the latest figure, recorded in Q4 2025.

• Quarterly Treasury Shares rose 19.0% year-over-year to -$5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.0 million (up 19.0% YoY) and the FY2025 annual result came in at -$5.0 million, up 19.0% from the prior year.
• Treasury Shares climbed to -$5.0 million in Q4 2025 per NBP's latest filing, from -$5.2 million in the prior quarter.
• Over the last five years, Treasury Shares for NBP reached as high as $6.8 million in Q2 2024 and fell as low as $231766.3 in Q4 2021.
• A 5-year average of $3.6 million and a median of $5.3 million in 2025 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares soared 164.06% — and 2024, when it tumbled 178.91%.
• Year by year, Treasury Shares stood at $3.0 million in 2022, then surged by 164.06% to $7.9 million in 2023, then plunged by 178.91% to -$6.2 million in 2024, then increased by 19.0% to -$5.0 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered -$5.0 million, -$5.2 million, and -$5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.